TEKLA CAPITAL MANAGEMENT LLC Blueprint Medicines Corporation Transaction History

TEKLA CAPITAL MANAGEMENT LLC portfolio value:

$0
portfolio value

TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:

+30.45%
quarter

Blueprint Medicines Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -111.11K shares -5.61M $65.89 0
Q2 2022 share Increase +14.26% 13.86K shares -600K $50.51 111.11K
Q1 2022 share Increase 0.00% 97.25K shares 6.21M $63.88 97.25K
Q3 2021 share Decrease -100.00% -122.69K shares -10.79M $102.81 0
Q2 2021 share 0.00% 0 shares -1.13M $87.96 122.69K
Q1 2021 share 0.00% 0 shares -1.83M $97.23 122.69K
Q4 2020 share Decrease -27.83% -47.31K shares -2M $112.15 122.69K
Q3 2020 share Increase +43.77% 51.76K shares 6.53M $92.7 170.01K
Q2 2020 share Decrease -15.13% -21.08K shares 1.07M $78 118.25K
Q1 2020 share Increase +19.17% 22.41K shares -1.21M $58.48 139.33K
Q4 2019 share Increase +15.86% 16.00K shares 1.95M $80.11 116.92K
Q3 2019 share Increase +6.25% 5.94K shares -1.54M $73.47 100.91K
Q2 2019 share Decrease -17.93% -20.74K shares -304K $94.33 94.97K
Q1 2019 share Decrease -7.58% -9.48K shares 2.51M $80.05 115.72K
Q4 2018 share Decrease -14.24% -20.79K shares -4.64M $53.91 125.20K
Q3 2018 share 0.00% 0 shares 2.12M $78.06 146.00K
Q2 2018 share Increase +96.71% 71.78K shares 2.46M $63.48 146.00K
Q1 2018 share Increase 0.00% 74.22K shares 6.80M $91.7 74.22K